Document Detail


Exaggerated luminal loss a few minutes after successful percutaneous transluminal coronary angioplasty in patients with recent myocardial infarction compared with stable angina: an intracoronary ultrasound study.
MedLine Citation:
PMID:  9143764     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This study investigates the mechanisms of exaggerated acute luminal loss after successful coronary angioplasty in patients with recent myocardial infarction compared with stable angina by angiography and intracoronary ultrasound (ICUS). We studied 15 consecutive patients (group 1) who, after a successful thrombolysis for myocardial infarction, underwent delayed (8 +/- 2 days after the myocardial infarction) successful balloon coronary angioplasty. Group 1 patients were individually matched with 15 stable angina patients (group 2). The percentage of stenosis and acute luminal loss were measured by quantitative coronary analysis. The ultrasound characteristics of lumen pathology were described as soft, hard, calcified, eccentric, concentric, thrombotic, and dissection lesions. Matching by stenosis location, reference diameter, sex, and age resulted in 2 comparable groups of 15 lesions with identical baseline characteristics. Immediately after percutaneous transluminal coronary angioplasty (PTCA), the minimal luminal diameter increased from 0.5 +/- 0.3 mm to 2.4 +/- 0.3 mm and from 0.5 +/- 0.2 mm to 2.4 +/- 0.3 mm in groups 1 and 2, respectively. Similar balloon sizes were used in both groups. The acute luminal loss (the difference between the maximal dilated balloon diameter and the minimal luminal diameter) immediately after PTCA was 0.4 +/- 0.2 mm and 0.3 +/- 0.3 mm (14 +/- 8% and 10 +/- 11% of balloon size) (P = not significant [NS]) in groups 1 and 2, respectively. After ICUS (mean 24 min after the last balloon deflation), the acute luminal loss was 0.9 +/- 0.3 mm and 0.5 +/- 0.4 mm (29 +/- 11% and 17 +/- 8% of balloon size) (P = 0.01) in groups 1 and 2, respectively. There was a significantly higher prevalence of intracoronary thrombus formation as detected by ICUS in group 1 compared with group 2 (80% vs. 20%; P < 0.001). In matched groups of successfully treated coronary angioplasty, patients with recent myocardial infarction had a similar magnitude of acute gained luminal loss immediately after the procedure. However, an exaggerated luminal loss a few minutes after the last balloon deflation in patients with recent myocardial infarction was noted because of mural thrombus formation compared with patients with stable angina.
Authors:
T M Lee; C C Chu; Y M Hsu; M F Chen; C S Liau; Y T Lee
Related Documents :
6211084 - Percutaneous transluminal coronary angioplasty: report from the registry of the nationa...
17956874 - The danish multicentre randomized study of fibrinolytic therapy vs. primary angioplasty...
15566914 - Comparison of late (four years) functional health status between percutaneous translumi...
2960224 - Percutaneous transluminal coronary angioplasty in patients with prior myocardial infarc...
15037554 - Nitric oxide and cardiac muscarinic control in humans.
21562004 - Proton pump inhibitor use and risk of adverse cardiovascular events in aspirin treated ...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Catheterization and cardiovascular diagnosis     Volume:  41     ISSN:  0098-6569     ISO Abbreviation:  Cathet Cardiovasc Diagn     Publication Date:  1997 May 
Date Detail:
Created Date:  1997-07-31     Completed Date:  1997-07-31     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7508512     Medline TA:  Cathet Cardiovasc Diagn     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  32-9     Citation Subset:  IM    
Affiliation:
Center for Cardiovascular Research, College of Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aneurysm, Dissecting / diagnosis,  therapy
Angina Pectoris / diagnosis,  therapy*
Angioplasty, Transluminal, Percutaneous Coronary*
Coronary Aneurysm / diagnosis,  therapy
Coronary Angiography*
Coronary Thrombosis / diagnosis,  therapy*
Female
Humans
Male
Middle Aged
Myocardial Infarction / diagnosis,  therapy*
Prospective Studies
Recurrence
Sensitivity and Specificity
Signal Processing, Computer-Assisted
Thrombolytic Therapy*
Tissue Plasminogen Activator / administration & dosage
Ultrasonography, Interventional*
Chemical
Reg. No./Substance:
EC 3.4.21.68/Tissue Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Left main intervention revisited: early and late outcome of PTCA and stenting.
Next Document:  Comparison of bailout versus elective stenting: time to reassess our benchmarks of outcome.